Betamethasone Sodium Phosphate

Spezifikationen

151-73-5CAS-Nummer

205-797-0EG-Nummer

disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphateIUPAC-Name

C22H28FNa2O8PChemische Formel

516.4 g/molMolekulargewicht

151-73-5; Betamethasone sodium phosphate; Betamethasone disodium phosphate; Betamethasone 21-disodium phosphate; Betamethasone 21-phosphate disodium; Betamethasone 21-phosphate disodium salt; Betamethazone disodium phosphate; DTXSID8047137; 7BK02SCL3W; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-(disodium phosphate); NSC-90616; CHEBI:3078; DTXCID6027137; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11beta,16beta)-; betamethason sodium phosphate; Vistamethasone; Betam-ophtal; Vistamethasone n; NSC90616; RefChem:54528; 205-797-0; Bentelan; Betamethasone Sodium Phosphate, USP; Betnesol; Betamethasone 21-phosphate sodium; MFCD00200361; Vista-Methasone; C22H28FNa2O8P; beta-Methasone disodium phosphate; Disodium betamethasone 21-phosphate; beta-Methasone sodium phosphate; beta-Methasone phosphate; Celestone Phosphate Injection; NSC 90616; disodium 9-fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate; disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate; beta-Methasone, disodium phosphate; EINECS 205-797-0; UNII-7BK02SCL3W; Betamethasone sodium phosphate [USP:JAN]; SCHEMBL8418; sodium betamethasone phosphate; MSK162020Na; orb1705434; orb3025857; CHEMBL1200762; Betamethasone sodium phosphate CRS; Bentelan; Betamethasone 21-disodium phosphate; Betamethasone 21-phosphate disodium salt; Betamethasone disodium phosphate; Tox21_302467; AKOS015896371; AC-2162; FB18567; NCGC00256717-01; AS-62442; CAS-151-73-5; DA-51070; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11.beta.,16.beta.)-; Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 21-(dihydrogen phosphate), disodium salt; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl-, 21-(dihydrogen phosphate), disodium salt; SY060170; Betamethasone sodium phosphate (JP18/USP); BETAMETHASONE SODIUM PHOSPHATE [JAN]; B4110; Betamethasone 21-phosphate disodium, >=97%; BETAMETHASONE SODIUM PHOSPHATE [MART.]; BETAMETHASONE SODIUM PHOSPHATE [VANDF]; BETAMETHASONE SODIUM PHOSPHATE [USP-RS]; BETAMETHASONE SODIUM PHOSPHATE [WHO-DD]; D00972; T20763; BETAMETHASONE SODIUM PHOSPHATE [GREEN BOOK]; F986710; BETAMETHASONE SODIUM PHOSPHATE [EP IMPURITY]; BETAMETHASONE SODIUM PHOSPHATE [EP MONOGRAPH]; BETAMETHASONE SODIUM PHOSPHATE [ORANGE BOOK]; BETAMETHASONE SODIUM PHOSPHATE [USP MONOGRAPH]; Q27105936; CELESTONE SOLUSPAN COMPONENT BETAMETHASONE SODIUM PHOSPHATE; Betamethasone sodium phosphate, European Pharmacopoeia (EP) Reference Standard; Betamethasone sodium phosphate, United States Pharmacopeia (USP) Reference Standard; (11b,16b)-9-Fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)pregna-1,4-diene-3,20-dione sodium salt; 9-Fluoro-11b,17,21-trihydroxy- 16b-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate) sodium salt; disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate; sodium 2-((8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl phosphate; Betamethason natri phopshatSynonyme